BUDESONIDE

BUDESONIDE was reported 97871 times

BUDESONIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL HIATUS HERNIA 131 0.5746
1 VAGINAL FLATULENCE 167 0.5512
2 SPIROMETRY ABNORMAL 307 0.5134
3 MITE ALLERGY 313 0.4779
4 ACQUIRED FACTOR V DEFICIENCY 47 0.4273
5 PULMONARY VASCULITIS 211 0.3922
6 TOTAL LUNG CAPACITY ABNORMAL 148 0.3805
7 EOSINOPHILIC BRONCHITIS 74 0.3700
8 MYCOTIC ALLERGY 315 0.3684
9 COAGULATION FACTOR DEFICIENCY 55 0.3416
10 DUST ALLERGY 330 0.3364
11 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 273 0.2945
12 MALIGNANT MELANOMA STAGE 0 60 0.2871
13 STEROID DEPENDENCE 221 0.2517
14 CAPILLARITIS 69 0.2500
15 CONJUNCTIVITIS ALLERGIC 313 0.2112
16 GROWTH FAILURE 68 0.1977
17 CATARRH 173 0.1914
18 EJECTION FRACTION 107 0.1842
19 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 133 0.1814
20 TOTAL LUNG CAPACITY INCREASED 49 0.1801
21 LARYNGEAL STENOSIS 101 0.1747
22 SENSITISATION 127 0.1673
23 REVERSIBLE AIRWAYS OBSTRUCTION 85 0.1673
24 VOCAL CORD DYSFUNCTION 82 0.1663
25 ENCEPHALITIS CYTOMEGALOVIRUS 71 0.1621
26 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 289 0.1416
27 NEURITIS 214 0.1385
28 ANALGESIC THERAPY 42 0.1308
29 FACTOR V LEIDEN MUTATION 51 0.1285
30 GRANULOMA SKIN 101 0.1230
31 FEMALE GENITAL TRACT FISTULA 202 0.1182
32 CHRONIC SINUSITIS 427 0.1137
33 VITAL CAPACITY DECREASED 50 0.1116
34 RESPIRATORY SYMPTOM 311 0.1092
35 FULL BLOOD COUNT ABNORMAL 1152 0.1088
36 BRONCHIAL SECRETION RETENTION 134 0.1052
37 PULMONARY FUNCTION TEST ABNORMAL 162 0.1039
38 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 54 0.1033
39 NORMOCHROMIC NORMOCYTIC ANAEMIA 308 0.1024
40 BURNS SECOND DEGREE 169 0.0962
41 BRONCHIECTASIS 632 0.0937
42 BREATH SOUNDS ABNORMAL 456 0.0924
43 BACTERIAL DISEASE CARRIER 67 0.0919
44 CUSHINGOID 282 0.0878
45 HYPERTENSIVE URGENCY 48 0.0866
46 BLOOD IMMUNOGLOBULIN E INCREASED 209 0.0862
47 PROCTITIS 239 0.0852
48 TOTAL LUNG CAPACITY DECREASED 135 0.0845
49 FORCED EXPIRATORY VOLUME DECREASED 236 0.0832
50 RHINITIS ALLERGIC 370 0.0830
51 OBSTRUCTIVE AIRWAYS DISORDER 913 0.0820
52 POLYCYSTIC OVARIES 124 0.0799
53 ADRENAL SUPPRESSION 67 0.0795
54 NASAL POLYPS 354 0.0718
55 BLOOD PARATHYROID HORMONE DECREASED 105 0.0708
56 RADICULOPATHY 185 0.0701
57 SINUSITIS FUNGAL 56 0.0698
58 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 140 0.0657
59 MACULAR DEGENERATION 769 0.0643
60 INTENTIONAL DEVICE MISUSE 279 0.0632
61 EPSTEIN-BARR VIRAEMIA 70 0.0631
62 SPUTUM CULTURE POSITIVE 50 0.0616
63 DRUG SPECIFIC ANTIBODY 82 0.0599
64 OBSTRUCTIVE SLEEP APNOEA SYNDROME 86 0.0589
65 LABILE BLOOD PRESSURE 69 0.0581
66 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 951 0.0559
67 LUNG OPACITY 147 0.0557
68 ILEAL STENOSIS 97 0.0545
69 ALLERGIC GRANULOMATOUS ANGIITIS 44 0.0536
70 EJECTION FRACTION ABNORMAL 64 0.0522
71 NASAL OBSTRUCTION 97 0.0517
72 MALIGNANT MELANOMA IN SITU 64 0.0517
73 HYPOPNOEA 178 0.0512
74 CHEST X-RAY ABNORMAL 151 0.0492
75 SKIN STRIAE 73 0.0490
76 COLITIS MICROSCOPIC 228 0.0481
77 NEUROLOGICAL SYMPTOM 266 0.0465
78 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 61 0.0463
79 SUPERINFECTION 69 0.0460
80 ADENOVIRUS INFECTION 133 0.0458
81 PANNICULITIS 109 0.0450
82 STENOTROPHOMONAS INFECTION 61 0.0450
83 FAECAL CALPROTECTIN INCREASED 140 0.0442
84 PLEURITIC PAIN 122 0.0442
85 ASTHMA 4882 0.0431
86 HIRSUTISM 57 0.0429
87 WHEEZING 2514 0.0424
88 GASTROINTESTINAL WALL THICKENING 63 0.0421
89 PULMONARY ALVEOLAR HAEMORRHAGE 232 0.0413
90 NEPHRECTOMY 61 0.0410
91 BK VIRUS INFECTION 135 0.0400
92 ALCOHOL POISONING 107 0.0399
93 GRAFT VERSUS HOST DISEASE IN SKIN 88 0.0399
94 EAR PRURITUS 139 0.0396
95 ARTERIOSCLEROSIS CORONARY ARTERY 262 0.0395
96 RHEUMATOID NODULE 108 0.0392
97 EOSINOPHIL COUNT INCREASED 323 0.0387
98 VASCULITIS 440 0.0377
99 UPPER-AIRWAY COUGH SYNDROME 310 0.0376
100 PRODUCT RESIDUE PRESENT 201 0.0372
101 RHINITIS 294 0.0364
102 THERAPEUTIC REACTION TIME DECREASED 106 0.0363
103 RALES 211 0.0363
104 MULTIPLE ALLERGIES 281 0.0358
105 SPUTUM DISCOLOURED 338 0.0356
106 RHONCHI 49 0.0355
107 SINUS OPERATION 83 0.0348
108 ASTHMATIC CRISIS 127 0.0347
109 HEPATORENAL SYNDROME 58 0.0343
110 HYPERAESTHESIA TEETH 43 0.0340
111 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 48 0.0340
112 COLITIS ULCERATIVE 1478 0.0330
113 FREQUENT BOWEL MOVEMENTS 875 0.0324
114 ARTERIOSCLEROSIS 301 0.0319
115 CARDIAC MURMUR 274 0.0316
116 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1520 0.0316
117 IMPAIRED QUALITY OF LIFE 437 0.0304
118 EOSINOPHILIC OESOPHAGITIS 84 0.0303
119 ACUTE GRAFT VERSUS HOST DISEASE 135 0.0295
120 PULMONARY FIBROSIS 549 0.0286
121 DRUG TOLERANCE DECREASED 80 0.0285
122 BENIGN PROSTATIC HYPERPLASIA 145 0.0281
123 THROAT CLEARING 105 0.0280
124 CYTOMEGALOVIRUS INFECTION REACTIVATION 119 0.0269
125 BLOOD LACTIC ACID INCREASED 138 0.0262
126 HYPERPHOSPHATAEMIA 56 0.0260
127 PAROSMIA 196 0.0259
128 NODULE 331 0.0253
129 SKIN NECROSIS 131 0.0252
130 EOSINOPHILIA 436 0.0249
131 PRODUCTIVE COUGH 1184 0.0248
132 GRAFT VERSUS HOST DISEASE 178 0.0247
133 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1264 0.0242
134 ABSCESS INTESTINAL 52 0.0241
135 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1705 0.0239
136 ORAL CANDIDIASIS 315 0.0239
137 GINGIVAL PAIN 190 0.0238
138 RESPIRATORY TRACT INFECTION VIRAL 55 0.0236
139 RHEUMATOID FACTOR POSITIVE 136 0.0235
140 BLOOD TEST ABNORMAL 322 0.0229
141 PRESCRIBED UNDERDOSE 456 0.0228
142 ENDOMETRIOSIS 108 0.0226
143 DRUG DELIVERY SYSTEM ISSUE 44 0.0223
144 EMPHYSEMA 225 0.0223
145 ANAL FISSURE 117 0.0218
146 MUCOUS STOOLS 107 0.0216
147 BRONCHOSPASM 297 0.0208
148 SPUTUM INCREASED 45 0.0208
149 VARICELLA ZOSTER VIRUS INFECTION 43 0.0207
150 INCREASED BRONCHIAL SECRETION 53 0.0207
151 LOSS OF THERAPEUTIC RESPONSE 66 0.0207
152 CYTOMEGALOVIRUS COLITIS 47 0.0204
153 DEFAECATION URGENCY 143 0.0204
154 HAEMOPTYSIS 562 0.0201
155 ASPIRATION 220 0.0201
156 POLYP 131 0.0200
157 BRONCHIOLITIS 70 0.0199
158 INFECTION SUSCEPTIBILITY INCREASED 43 0.0196
159 CYSTITIS HAEMORRHAGIC 79 0.0196
160 DRUG LEVEL BELOW THERAPEUTIC 108 0.0196
161 HAEMATOCHEZIA 1080 0.0195
162 BLOOD CALCIUM INCREASED 169 0.0193
163 PARAESTHESIA ORAL 277 0.0192
164 HYPOGAMMAGLOBULINAEMIA 124 0.0189
165 RHINOVIRUS INFECTION 73 0.0187
166 PULMONARY MASS 279 0.0187
167 DRUG SPECIFIC ANTIBODY PRESENT 120 0.0184
168 NEUTROPHILIA 104 0.0183
169 IRON DEFICIENCY 82 0.0182
170 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 50 0.0181
171 LARGE INTESTINAL ULCER 49 0.0180
172 HYPOXIA 633 0.0180
173 COLITIS 680 0.0179
174 GROWTH RETARDATION 52 0.0176
175 VAGINAL DISCHARGE 178 0.0176
176 ASPERGILLUS INFECTION 115 0.0175
177 INCREASED UPPER AIRWAY SECRETION 89 0.0173
178 RESPIRATORY TRACT INFECTION 440 0.0169
179 ADRENAL INSUFFICIENCY 204 0.0168
180 DRUG LEVEL ABOVE THERAPEUTIC 77 0.0168
181 ULCER 264 0.0166
182 ATELECTASIS 160 0.0165
183 PNEUMONIA VIRAL 52 0.0163
184 ERYTHEMA NODOSUM 57 0.0162
185 ORTHOPNOEA 51 0.0160
186 RECTAL HAEMORRHAGE 682 0.0159
187 SINUS DISORDER 314 0.0158
188 RESPIRATORY SYNCYTIAL VIRUS INFECTION 138 0.0158
189 LUNG DISORDER 775 0.0158
190 PSEUDOMONAS INFECTION 135 0.0157
191 INTESTINAL STENOSIS 66 0.0156
192 RED BLOOD CELL SEDIMENTATION RATE INCREASED 173 0.0156
193 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 85 0.0156
194 JAUNDICE CHOLESTATIC 55 0.0156
195 APHTHOUS ULCER 120 0.0155
196 CROHN'S DISEASE 105 0.0153
197 SECRETION DISCHARGE 191 0.0152
198 GASTROOESOPHAGEAL REFLUX DISEASE 1221 0.0152
199 TACHYPNOEA 206 0.0151
200 DIARRHOEA HAEMORRHAGIC 141 0.0151
201 PULMONARY FUNCTION TEST DECREASED 66 0.0151
202 HYPOTHYROIDISM 478 0.0150
203 PLATELET COUNT INCREASED 192 0.0147
204 DYSPNOEA EXERTIONAL 553 0.0147
205 LIQUID PRODUCT PHYSICAL ISSUE 107 0.0147
206 UPPER RESPIRATORY TRACT INFECTION 676 0.0146
207 PARANASAL SINUS DISCOMFORT 55 0.0145
208 SLEEP APNOEA SYNDROME 276 0.0144
209 PNEUMONIA FUNGAL 57 0.0144
210 INCREASED TENDENCY TO BRUISE 131 0.0142
211 MIDDLE INSOMNIA 263 0.0141
212 CHEST DISCOMFORT 1440 0.0140
213 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 71 0.0140
214 OBSTRUCTION 56 0.0140
215 DEVICE FAILURE 213 0.0140
216 HYPERCHOLESTEROLAEMIA 135 0.0140
217 SCOLIOSIS 86 0.0139
218 HYPOVOLAEMIA 81 0.0138
219 SARCOIDOSIS 65 0.0137
220 DEVICE USE ISSUE 239 0.0136
221 CYSTIC FIBROSIS 75 0.0135
222 HAEMORRHAGIC DIATHESIS 48 0.0135
223 DRUG LEVEL DECREASED 137 0.0134
224 BRONCHOPULMONARY ASPERGILLOSIS 104 0.0134
225 ENERGY INCREASED 79 0.0134
226 PROCTALGIA 86 0.0134
227 ABDOMINAL ADHESIONS 42 0.0133
228 GASTROINTESTINAL INFLAMMATION 104 0.0133
229 SKIN ATROPHY 76 0.0132
230 CANDIDA INFECTION 222 0.0131
231 TUBULOINTERSTITIAL NEPHRITIS 245 0.0131
232 RESPIRATION ABNORMAL 90 0.0130
233 SNEEZING 292 0.0130
234 HYPOALBUMINAEMIA 101 0.0130
235 MICTURITION URGENCY 146 0.0128
236 INCREASED APPETITE 242 0.0127
237 CARPAL TUNNEL SYNDROME 177 0.0126
238 NASAL CONGESTION 737 0.0125
239 DYSPHONIA 725 0.0124
240 ENTERITIS 79 0.0123
241 C-REACTIVE PROTEIN ABNORMAL 79 0.0123
242 GLOMERULAR FILTRATION RATE DECREASED 151 0.0123
243 CLOSTRIDIUM DIFFICILE INFECTION 266 0.0122
244 IRON DEFICIENCY ANAEMIA 112 0.0121
245 AORTIC STENOSIS 42 0.0120
246 ABNORMAL LOSS OF WEIGHT 82 0.0120
247 COUGH 3367 0.0120
248 HYPOMANIA 44 0.0120
249 BLOOD COUNT ABNORMAL 181 0.0119
250 END STAGE RENAL DISEASE 217 0.0119
251 URINE ABNORMALITY 54 0.0119
252 SEASONAL ALLERGY 168 0.0119
253 ELECTROLYTE IMBALANCE 137 0.0118
254 DYSPNOEA 6673 0.0118
255 BODY TEMPERATURE DECREASED 116 0.0118
256 INFLAMMATORY MARKER INCREASED 58 0.0117
257 INFUSION SITE SWELLING 73 0.0116
258 ABDOMINAL ABSCESS 51 0.0115
259 PROCEDURAL PAIN 320 0.0115
260 RESPIRATORY DISTRESS 317 0.0115
261 ABDOMINAL TENDERNESS 57 0.0115
262 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 384 0.0114
263 BACTERIAL INFECTION 212 0.0114
264 PROTEIN URINE PRESENT 56 0.0112
265 GENERALISED OEDEMA 139 0.0112
266 BOWEL MOVEMENT IRREGULARITY 86 0.0112
267 BODY HEIGHT DECREASED 120 0.0112
268 CANDIDIASIS 45 0.0112
269 SINUS CONGESTION 150 0.0111
270 IMPAIRED WORK ABILITY 236 0.0110
271 APHONIA 154 0.0110
272 RHINORRHOEA 709 0.0110
273 TRANSAMINASES INCREASED 240 0.0108
274 ANAL INCONTINENCE 96 0.0107
275 BRONCHITIS 789 0.0106
276 SMALL INTESTINAL OBSTRUCTION 131 0.0106
277 INFLAMMATORY BOWEL DISEASE 104 0.0106
278 COLECTOMY 60 0.0106
279 PULMONARY CONGESTION 139 0.0105
280 SINUSITIS 1071 0.0104
281 SYMPTOM RECURRENCE 62 0.0104
282 ANAL FISTULA 55 0.0103
283 SENSITIVITY TO WEATHER CHANGE 54 0.0103
284 HYPERCALCAEMIA 126 0.0102
285 LOWER RESPIRATORY TRACT INFECTION 463 0.0102
286 CLOSTRIDIUM DIFFICILE COLITIS 107 0.0101
287 INTENTIONAL PRODUCT MISUSE 883 0.0101
288 OROPHARYNGEAL DISCOMFORT 91 0.0101
289 PHARYNGITIS STREPTOCOCCAL 109 0.0101
290 HIATUS HERNIA 130 0.0100
291 BASAL CELL CARCINOMA 156 0.0100
292 CYTOMEGALOVIRUS INFECTION 166 0.0100
293 BLOOD POTASSIUM DECREASED 300 0.0100
294 BLOOD PRESSURE SYSTOLIC INCREASED 194 0.0099
295 PROTEINURIA 189 0.0099
296 FAECES SOFT 72 0.0099
297 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 169 0.0098
298 POOR VENOUS ACCESS 102 0.0098
299 ANAL ABSCESS 53 0.0098
300 RESPIRATORY DISORDER 293 0.0098
301 WEIGHT FLUCTUATION 102 0.0097
302 DIALYSIS 137 0.0096
303 PULMONARY EMBOLISM 909 0.0096
304 C-REACTIVE PROTEIN INCREASED 347 0.0095
305 FRUSTRATION TOLERANCE DECREASED 77 0.0095
306 STAPHYLOCOCCAL SEPSIS 47 0.0095
307 CONDITION AGGRAVATED 2893 0.0095
308 UMBILICAL HERNIA 44 0.0094
309 INTENTIONAL PRODUCT USE ISSUE 820 0.0094
310 ASPHYXIA 76 0.0093
311 OXYGEN SATURATION DECREASED 520 0.0092
312 PNEUMOTHORAX 146 0.0092
313 EAR INFECTION 243 0.0091
314 MALNUTRITION 102 0.0091
315 CYANOSIS 143 0.0091
316 HYPOPHOSPHATAEMIA 67 0.0091
317 SWELLING FACE 589 0.0090
318 JOINT INJURY 193 0.0090
319 FIBROMYALGIA 219 0.0090
320 INFUSION SITE EXTRAVASATION 56 0.0090
321 DRY THROAT 91 0.0089
322 DEVICE MALFUNCTION 628 0.0089
323 MYASTHENIA GRAVIS 72 0.0089
324 SWOLLEN TONGUE 278 0.0089
325 INSURANCE ISSUE 136 0.0089
326 SMALL FOR DATES BABY 44 0.0089
327 PERIORBITAL OEDEMA 46 0.0089
328 LARGE INTESTINE POLYP 61 0.0088
329 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 63 0.0088
330 INFUSION RELATED REACTION 582 0.0088
331 INFUSION SITE ERYTHEMA 74 0.0088
332 BLOOD IRON DECREASED 104 0.0088
333 SYNOVITIS 158 0.0088
334 PHARYNGOLARYNGEAL PAIN 46 0.0086
335 ANOSMIA 125 0.0086
336 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 56 0.0086
337 ARTHRITIS 676 0.0086
338 FISTULA 96 0.0085
339 BLOOD PRESSURE INCREASED 1303 0.0085
340 PNEUMONIA 2759 0.0085
341 EXERCISE TOLERANCE DECREASED 49 0.0085
342 MULTIPLE ORGAN DYSFUNCTION SYNDROME 241 0.0085
343 INFUSION SITE PAIN 109 0.0085
344 NASAL DRYNESS 53 0.0084
345 HYPERLIPIDAEMIA 101 0.0084
346 RESPIRATORY TRACT CONGESTION 134 0.0084
347 FOOD ALLERGY 65 0.0084
348 HUNGER 117 0.0084
349 LIVER FUNCTION TEST INCREASED 179 0.0083
350 BLOOD PRESSURE FLUCTUATION 200 0.0083
351 LACRIMATION INCREASED 250 0.0083
352 LUNG INFECTION 128 0.0082
353 RESPIRATORY RATE INCREASED 73 0.0082
354 PSYCHOMOTOR HYPERACTIVITY 136 0.0082
355 DIVERTICULUM 58 0.0082
356 IMMUNOSUPPRESSION 72 0.0082
357 TROPONIN INCREASED 62 0.0081
358 GASTROINTESTINAL INFECTION 73 0.0081
359 APPENDICITIS 76 0.0081
360 BLOOD PRESSURE DIASTOLIC DECREASED 60 0.0081
361 NEPHROPATHY TOXIC 90 0.0080
362 HYPERTENSION 1684 0.0079
363 NASAL DISCOMFORT 63 0.0079
364 DRUG ERUPTION 140 0.0079
365 MYOPATHY 68 0.0079
366 TINNITUS 361 0.0078
367 ANGIOPATHY 44 0.0078
368 ACUTE RESPIRATORY FAILURE 151 0.0078
369 DERMATITIS CONTACT 89 0.0078
370 FLANK PAIN 73 0.0078
371 THERAPEUTIC PRODUCT EFFECT DECREASED 347 0.0077
372 HEART RATE INCREASED 767 0.0077
373 ECZEMA 405 0.0077
374 ABDOMINAL PAIN 1794 0.0077
375 WEIGHT DECREASED 2113 0.0076
376 HEART RATE ABNORMAL 42 0.0075
377 FACE OEDEMA 127 0.0075
378 HYPERGLYCAEMIA 274 0.0075
379 SKIN LESION 206 0.0075
380 CORONARY ARTERY DISEASE 227 0.0075
381 THROAT IRRITATION 336 0.0075
382 SKIN LACERATION 81 0.0074
383 COAGULOPATHY 124 0.0074
384 PERIPHERAL SWELLING 1143 0.0074
385 PHARYNGITIS 92 0.0074
386 PRODUCT PRESCRIBING ISSUE 161 0.0074
387 HAIR GROWTH ABNORMAL 51 0.0074
388 EPSTEIN-BARR VIRUS INFECTION 46 0.0074
389 OROPHARYNGEAL PAIN 680 0.0073
390 OSTEOPOROSIS 301 0.0073
391 PRODUCT USE IN UNAPPROVED INDICATION 1811 0.0073
392 DRUG INTOLERANCE 705 0.0073
393 HERPES VIRUS INFECTION 42 0.0073
394 NEPHROPATHY 68 0.0073
395 BLOOD URIC ACID INCREASED 42 0.0073
396 PRODUCT TASTE ABNORMAL 98 0.0072
397 GASTROENTERITIS VIRAL 130 0.0072
398 VIRAL INFECTION 238 0.0071
399 WEIGHT INCREASED 1601 0.0071
400 MIGRAINE 678 0.0071
401 TYPE 2 DIABETES MELLITUS 239 0.0071
402 THROMBOSIS 571 0.0071
403 HEART RATE DECREASED 249 0.0071
404 OFF LABEL USE 6203 0.0071
405 TRANSIENT ISCHAEMIC ATTACK 239 0.0071
406 FOREIGN BODY SENSATION IN EYES 45 0.0071
407 EYE PRURITUS 237 0.0070
408 PHARYNGEAL SWELLING 69 0.0070
409 PALPITATIONS 822 0.0070
410 PRODUCT USE ISSUE 1318 0.0070
411 OEDEMA PERIPHERAL 849 0.0070
412 THERAPY NON-RESPONDER 313 0.0070
413 DUODENAL ULCER 49 0.0069
414 NEUTROPHIL COUNT INCREASED 71 0.0069
415 SLEEP DISORDER 489 0.0069
416 OLIGURIA 43 0.0069
417 INFLAMMATION 352 0.0068
418 CONTUSION 654 0.0068
419 NIGHTMARE 235 0.0068
420 EAR PAIN 132 0.0068
421 BLOOD MAGNESIUM DECREASED 58 0.0067
422 INTESTINAL OBSTRUCTION 253 0.0067
423 RESPIRATORY FAILURE 489 0.0067
424 DYSPEPSIA 658 0.0067
425 HAEMOGLOBIN ABNORMAL 43 0.0067
426 INTENTIONAL DRUG MISUSE 139 0.0066
427 GOUT 119 0.0066
428 MUSCLE SPASMS 1214 0.0066
429 ABDOMINAL PAIN LOWER 167 0.0066
430 ABNORMAL FAECES 54 0.0066
431 ANAPHYLACTIC REACTION 363 0.0066
432 CHOKING 128 0.0066
433 ABDOMINAL DISTENSION 684 0.0065
434 SKIN ULCER 169 0.0065
435 HEART RATE IRREGULAR 147 0.0065
436 INFLUENZA 724 0.0065
437 PYREXIA 2246 0.0065
438 BLOOD CREATININE INCREASED 423 0.0065
439 FLATULENCE 367 0.0065
440 RIB FRACTURE 133 0.0065
441 PRODUCT SUPPLY ISSUE 46 0.0064
442 ACUTE HEPATIC FAILURE 88 0.0064
443 GLAUCOMA 124 0.0064
444 BLOOD PRESSURE ABNORMAL 128 0.0064
445 COVID-19 1129 0.0064
446 VITAMIN D DECREASED 55 0.0064
447 RETCHING 137 0.0064
448 TRICUSPID VALVE INCOMPETENCE 51 0.0064
449 ACNE 486 0.0064
450 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1151 0.0064
451 BRAIN FOG 100 0.0064
452 SUPRAVENTRICULAR TACHYCARDIA 61 0.0064
453 LOWER GASTROINTESTINAL HAEMORRHAGE 47 0.0064
454 DEEP VEIN THROMBOSIS 413 0.0063
455 UVEITIS 86 0.0063
456 HEPATITIS 162 0.0063
457 AUTOIMMUNE HEPATITIS 44 0.0063
458 PNEUMONIA BACTERIAL 58 0.0063
459 BLOOD ALBUMIN DECREASED 50 0.0063
460 ILLNESS 647 0.0063
461 SINUS TACHYCARDIA 89 0.0063
462 MEDICATION ERROR 348 0.0063
463 PHOTOSENSITIVITY REACTION 103 0.0062
464 BLOOD URINE PRESENT 118 0.0062
465 PANCREATITIS ACUTE 139 0.0062
466 THROMBOTIC MICROANGIOPATHY 60 0.0062
467 INABILITY TO AFFORD MEDICATION 61 0.0061
468 SHOCK HAEMORRHAGIC 50 0.0061
469 MUSCULOSKELETAL CHEST PAIN 95 0.0061
470 HYPOKALAEMIA 282 0.0061
471 NOCTURIA 74 0.0061
472 SYSTEMIC LUPUS ERYTHEMATOSUS 216 0.0061
473 OEDEMA 330 0.0061
474 ARTHROPOD BITE 45 0.0061
475 RASH PRURITIC 329 0.0061
476 ACCIDENTAL OVERDOSE 222 0.0061
477 INTESTINAL PERFORATION 68 0.0061
478 NIGHT SWEATS 195 0.0060
479 FACIAL PAIN 54 0.0060
480 INITIAL INSOMNIA 62 0.0060
481 INTENTIONAL UNDERDOSE 44 0.0060
482 DYSGEUSIA 446 0.0060
483 PANCREATITIS 317 0.0060
484 PRODUCT DOSE OMISSION ISSUE 1761 0.0060
485 HEAD DISCOMFORT 106 0.0060
486 TACHYCARDIA 531 0.0060
487 NASOPHARYNGITIS 1100 0.0060
488 THROAT TIGHTNESS 161 0.0059
489 DEVICE DELIVERY SYSTEM ISSUE 162 0.0059
490 WHITE BLOOD CELL COUNT INCREASED 227 0.0059
491 CATARACT 352 0.0059
492 PLEURAL EFFUSION 359 0.0059
493 HEPATIC ENCEPHALOPATHY 55 0.0059
494 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 323 0.0059
495 CHOLELITHIASIS 193 0.0059
496 PNEUMOCYSTIS JIROVECII PNEUMONIA 59 0.0059
497 LEUKOCYTOSIS 105 0.0058
498 FUNGAL INFECTION 193 0.0058
499 JOINT SWELLING 698 0.0058
500 ABSCESS 92 0.0058
501 STAPHYLOCOCCAL INFECTION 190 0.0058
502 HYPERTENSIVE CRISIS 64 0.0057
503 DIVERTICULITIS 158 0.0057
504 HAEMORRHOIDS 111 0.0057
505 GASTROINTESTINAL DISORDER 508 0.0057
506 FEELING JITTERY 108 0.0057
507 BACTERAEMIA 67 0.0056
508 AUTOIMMUNE DISORDER 55 0.0056
509 DIABETES MELLITUS 428 0.0056
510 COELIAC DISEASE 55 0.0056
511 POST PROCEDURAL HAEMORRHAGE 65 0.0056
512 RENAL PAIN 59 0.0056
513 TENDERNESS 58 0.0056
514 MUSCULOSKELETAL STIFFNESS 485 0.0055
515 NEURALGIA 134 0.0055
516 COVID-19 PNEUMONIA 65 0.0055
517 THERAPEUTIC RESPONSE SHORTENED 182 0.0055
518 ATRIAL FIBRILLATION 534 0.0055
519 MITRAL VALVE INCOMPETENCE 62 0.0055
520 OSTEOPENIA 83 0.0055
521 ANAPHYLACTIC SHOCK 141 0.0055
522 TREMOR 903 0.0054
523 VITAMIN D DEFICIENCY 53 0.0054
524 THIRST 97 0.0054
525 HYSTERECTOMY 47 0.0054
526 CONCUSSION 42 0.0054
527 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 253 0.0054
528 ALANINE AMINOTRANSFERASE INCREASED 332 0.0054
529 ASPARTATE AMINOTRANSFERASE INCREASED 286 0.0054
530 FLUID RETENTION 273 0.0054
531 SPINAL OSTEOARTHRITIS 47 0.0053
532 DRY MOUTH 434 0.0053
533 PRODUCT ADMINISTRATION ERROR 108 0.0053
534 SENSATION OF FOREIGN BODY 45 0.0053
535 HAEMATEMESIS 135 0.0053
536 ADVERSE DRUG REACTION 478 0.0053
537 HYPOMAGNESAEMIA 74 0.0053
538 DEVICE DEFECTIVE 92 0.0053
539 MALAISE 2320 0.0053
540 PRODUCT PRESCRIBING ERROR 126 0.0053
541 GASTROINTESTINAL PAIN 58 0.0053
542 MOUTH ULCERATION 111 0.0053
543 DIZZINESS POSTURAL 51 0.0053
544 THERAPY PARTIAL RESPONDER 82 0.0053
545 DISEASE RECURRENCE 250 0.0053
546 HEADACHE 3283 0.0052
547 POLLAKIURIA 218 0.0052
548 GENERAL PHYSICAL HEALTH DETERIORATION 604 0.0052
549 MUSCLE ATROPHY 66 0.0052
550 GASTROENTERITIS 76 0.0052
551 LUNG INFILTRATION 46 0.0052
552 CONJUNCTIVITIS 96 0.0052
553 DERMATITIS 108 0.0051
554 DECUBITUS ULCER 42 0.0051
555 DRUG DOSE OMISSION 851 0.0051
556 GASTRITIS 135 0.0051
557 ANAEMIA 977 0.0051
558 BLOOD POTASSIUM INCREASED 83 0.0051
559 POOR QUALITY SLEEP 110 0.0051
560 TREATMENT FAILURE 423 0.0051
561 CONSTIPATION 1109 0.0051
562 IMMUNE SYSTEM DISORDER 67 0.0051
563 FAECES DISCOLOURED 110 0.0051
564 BLOOD BILIRUBIN INCREASED 137 0.0051
565 VERTIGO 309 0.0051
566 EAR DISCOMFORT 52 0.0051
567 AGEUSIA 126 0.0050
568 PULMONARY HYPERTENSION 105 0.0050
569 ABDOMINAL DISCOMFORT 843 0.0050
570 HEPATIC ENZYME INCREASED 342 0.0050
571 INCONTINENCE 53 0.0050
572 SWELLING 469 0.0050
573 SEPSIS 557 0.0050
574 QUALITY OF LIFE DECREASED 67 0.0050
575 BLOOD SODIUM DECREASED 94 0.0050
576 CELLULITIS 251 0.0050
577 NERVOUSNESS 260 0.0050
578 CARDIOMEGALY 61 0.0050
579 PNEUMONITIS 135 0.0050
580 OESOPHAGITIS 54 0.0049
581 SKIN INFECTION 55 0.0049
582 POST PROCEDURAL COMPLICATION 94 0.0049
583 NEUROLEPTIC MALIGNANT SYNDROME 58 0.0049
584 CONTRAINDICATED PRODUCT ADMINISTERED 148 0.0049
585 CHEST PAIN 905 0.0049
586 DRUG INEFFECTIVE 6408 0.0049
587 LIGAMENT SPRAIN 48 0.0048
588 HYPERSENSITIVITY 895 0.0048
589 INCORRECT DOSE ADMINISTERED BY DEVICE 126 0.0048
590 DEVICE ISSUE 431 0.0048
591 HEPATOTOXICITY 107 0.0048
592 PRODUCT DOSE OMISSION IN ERROR 136 0.0048
593 PETECHIAE 50 0.0048
594 HAEMATOCRIT DECREASED 95 0.0048
595 CHROMATURIA 108 0.0048
596 EYE INFECTION 54 0.0048
597 ARTHROPATHY 265 0.0048
598 FATIGUE 3700 0.0047
599 THERAPEUTIC RESPONSE DECREASED 288 0.0047
600 FEELING COLD 132 0.0047
601 PALLOR 129 0.0047
602 DRUG INTERACTION 752 0.0047
603 DECREASED ACTIVITY 51 0.0047
604 RENAL DISORDER 218 0.0047
605 SQUAMOUS CELL CARCINOMA 44 0.0047
606 BODY TEMPERATURE INCREASED 95 0.0047
607 LYMPHOCYTE COUNT DECREASED 82 0.0046
608 PRODUCT DISTRIBUTION ISSUE 43 0.0046
609 TOOTH INFECTION 61 0.0046
610 ARTHRALGIA 1924 0.0046
611 EYE INFLAMMATION 44 0.0046
612 URTICARIA 772 0.0046
613 INSOMNIA 1226 0.0046
614 BLOOD UREA INCREASED 77 0.0046
615 BURNING SENSATION 322 0.0046
616 SPINAL FRACTURE 92 0.0046
617 MUSCULOSKELETAL DISCOMFORT 79 0.0046
618 DIARRHOEA 2951 0.0046
619 INFECTION 659 0.0045
620 HYPONATRAEMIA 256 0.0045
621 ERYTHEMA 930 0.0045
622 CIRCULATORY COLLAPSE 77 0.0045
623 TREATMENT NONCOMPLIANCE 247 0.0045
624 ILL-DEFINED DISORDER 274 0.0045
625 URINARY TRACT INFECTION 769 0.0045
626 MELAENA 99 0.0045
627 DRY EYE 224 0.0045
628 IRRITABLE BOWEL SYNDROME 96 0.0045
629 DERMATITIS ALLERGIC 56 0.0044
630 ASTHENIA 1672 0.0044
631 EPISTAXIS 330 0.0044
632 ANXIETY 1253 0.0044
633 HOSPITALISATION 676 0.0044
634 DEAFNESS 115 0.0044
635 HERNIA 85 0.0044
636 BLOOD PRESSURE DECREASED 292 0.0044
637 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 45 0.0044
638 ORAL PAIN 98 0.0044
639 CHOLECYSTITIS 52 0.0044
640 ILEUS 54 0.0043
641 MALIGNANT MELANOMA 58 0.0043
642 HEPATIC FAILURE 130 0.0043
643 HERPES ZOSTER 247 0.0043
644 PANCYTOPENIA 240 0.0043
645 IMMUNODEFICIENCY 64 0.0043
646 OSTEOARTHRITIS 182 0.0043
647 INTENTIONAL DOSE OMISSION 122 0.0043
648 HEPATOMEGALY 42 0.0043
649 CHILLS 500 0.0043
650 AGGRESSION 213 0.0043
651 IMPAIRED GASTRIC EMPTYING 58 0.0043
652 CARDIAC DISORDER 398 0.0042
653 MOOD ALTERED 116 0.0042
654 BACK PAIN 988 0.0042
655 SEPTIC SHOCK 185 0.0042
656 LIMB INJURY 115 0.0042
657 PAIN IN EXTREMITY 1247 0.0042
658 DYSPHAGIA 401 0.0042
659 DEVICE RELATED INFECTION 65 0.0042
660 TOOTHACHE 76 0.0042
661 SCHIZOPHRENIA 51 0.0042
662 PERICARDIAL EFFUSION 97 0.0042
663 ABDOMINAL PAIN UPPER 857 0.0042
664 UPPER GASTROINTESTINAL HAEMORRHAGE 70 0.0042
665 DEHYDRATION 550 0.0041
666 FOOT FRACTURE 78 0.0041
667 DISCOMFORT 251 0.0041
668 SKIN DISORDER 137 0.0041
669 NEPHROLITHIASIS 188 0.0041
670 ANGIOEDEMA 181 0.0041
671 RENAL FAILURE 543 0.0041
672 SCRATCH 43 0.0041
673 PRESYNCOPE 99 0.0041
674 CHRONIC KIDNEY DISEASE 308 0.0040
675 DRUG EFFECT LESS THAN EXPECTED 60 0.0040
676 ORAL HERPES 79 0.0040
677 IRRITABILITY 242 0.0040
678 ADVERSE REACTION 53 0.0040
679 REBOUND EFFECT 45 0.0040
680 COLD SWEAT 70 0.0040
681 LOCALISED INFECTION 96 0.0040
682 PNEUMONIA ASPIRATION 99 0.0040
683 RESTLESSNESS 145 0.0040
684 ORAL DISCOMFORT 55 0.0040
685 DRUG PRESCRIBING ERROR 76 0.0040
686 OBESITY 63 0.0040
687 PRODUCT AVAILABILITY ISSUE 90 0.0039
688 HYPOACUSIS 170 0.0039
689 RASH MACULAR 138 0.0039
690 SCAB 45 0.0039
691 RASH PAPULAR 88 0.0039
692 GAMMA-GLUTAMYLTRANSFERASE INCREASED 87 0.0039
693 BLOOD CALCIUM DECREASED 44 0.0039
694 MUSCULAR WEAKNESS 444 0.0039
695 THYROID DISORDER 60 0.0039
696 BURSITIS 47 0.0039
697 KIDNEY INFECTION 76 0.0039
698 PRODUCT USE COMPLAINT 61 0.0039
699 CYST 48 0.0039
700 MYALGIA 657 0.0039
701 EYE DISORDER 127 0.0039
702 PERIPHERAL COLDNESS 53 0.0039
703 DIZZINESS 1924 0.0039
704 RESTLESS LEGS SYNDROME 70 0.0038
705 RED BLOOD CELL COUNT DECREASED 110 0.0038
706 TASTE DISORDER 78 0.0038
707 LIP SWELLING 128 0.0038
708 HYPOPHAGIA 98 0.0038
709 LABORATORY TEST ABNORMAL 113 0.0038
710 BLOOD ALKALINE PHOSPHATASE INCREASED 95 0.0038
711 DRUG-INDUCED LIVER INJURY 120 0.0038
712 HEPATIC STEATOSIS 71 0.0038
713 ANKLE FRACTURE 59 0.0038
714 HEPATOCELLULAR INJURY 54 0.0038
715 TENDON RUPTURE 47 0.0038
716 GASTROINTESTINAL HAEMORRHAGE 318 0.0038
717 SOMNOLENCE 766 0.0038
718 VOMITING 1782 0.0038
719 RASH 1652 0.0038
720 LETHARGY 218 0.0038
721 ACUTE KIDNEY INJURY 579 0.0038
722 EXPOSURE DURING PREGNANCY 235 0.0038
723 CONFUSIONAL STATE 611 0.0038
724 FEELING HOT 231 0.0038
725 UPPER LIMB FRACTURE 75 0.0038
726 ARRHYTHMIA 178 0.0038
727 INTRAOCULAR PRESSURE INCREASED 48 0.0038
728 EYE HAEMORRHAGE 50 0.0037
729 RENAL IMPAIRMENT 311 0.0037
730 FEELING ABNORMAL 887 0.0037
731 PAIN 2255 0.0037
732 HAEMATOMA 95 0.0037
733 PRODUCT DOSE OMISSION 239 0.0037
734 ROTATOR CUFF SYNDROME 47 0.0037
735 CRYING 133 0.0037
736 PRODUCT QUALITY ISSUE 497 0.0037
737 HYPERHIDROSIS 471 0.0037
738 DRUG ADMINISTRATION ERROR 112 0.0036
739 DEPRESSION 828 0.0036
740 HAEMOGLOBIN DECREASED 373 0.0036
741 DECREASED APPETITE 837 0.0036
742 NAUSEA 2846 0.0036
743 ANGINA PECTORIS 103 0.0036
744 URINARY INCONTINENCE 106 0.0036
745 ADVERSE EVENT 328 0.0036
746 LIMB DISCOMFORT 110 0.0036
747 CYSTITIS 113 0.0035
748 PREGNANCY 71 0.0035
749 ORTHOSTATIC HYPOTENSION 61 0.0035
750 TOXIC EPIDERMAL NECROLYSIS 53 0.0035
751 DYSURIA 128 0.0035
752 CARDIAC FAILURE 279 0.0035
753 DEPRESSED MOOD 183 0.0035
754 HYPOTENSION 694 0.0035
755 NECK PAIN 193 0.0034
756 PRURITUS 1326 0.0034
757 HYPOCALCAEMIA 65 0.0034
758 PHARMACEUTICAL PRODUCT COMPLAINT 89 0.0034
759 PARALYSIS 49 0.0034
760 LYMPHADENOPATHY 121 0.0034
761 FEEDING DISORDER 69 0.0034
762 EYE SWELLING 126 0.0034
763 EATING DISORDER 72 0.0034
764 PHARYNGEAL OEDEMA 52 0.0034
765 CARDIAC FAILURE CONGESTIVE 271 0.0034
766 TOOTH DISORDER 75 0.0034
767 HYPOAESTHESIA 502 0.0034
768 INTERVERTEBRAL DISC PROTRUSION 73 0.0033
769 DRUG LEVEL INCREASED 55 0.0033
770 HYPOAESTHESIA ORAL 50 0.0033
771 MATERNAL EXPOSURE DURING PREGNANCY 295 0.0033
772 OCULAR HYPERAEMIA 157 0.0033
773 BLOOD CHOLESTEROL INCREASED 154 0.0033
774 TENDONITIS 51 0.0033
775 SURGERY 193 0.0033
776 WOUND 92 0.0033
777 PULMONARY OEDEMA 147 0.0033
778 THERAPEUTIC RESPONSE UNEXPECTED 147 0.0033
779 WRONG TECHNIQUE IN DRUG USAGE PROCESS 119 0.0033
780 MOOD SWINGS 104 0.0033
781 SCIATICA 52 0.0033
782 FALL 1085 0.0033
783 HYPOKINESIA 47 0.0032
784 VISUAL IMPAIRMENT 401 0.0032
785 HAEMORRHAGE 337 0.0032
786 PREMATURE BABY 97 0.0032
787 MASS 45 0.0032
788 ENCEPHALOPATHY 79 0.0032
789 APHASIA 97 0.0032
790 FOETAL EXPOSURE DURING PREGNANCY 261 0.0032
791 PANIC ATTACK 117 0.0032
792 AGITATION 234 0.0032
793 HAEMATURIA 109 0.0032
794 GLOSSODYNIA 71 0.0032
795 VISION BLURRED 431 0.0031
796 CARDIOGENIC SHOCK 45 0.0031
797 EXPOSURE VIA SKIN CONTACT 81 0.0031
798 DISSEMINATED INTRAVASCULAR COAGULATION 44 0.0031
799 THERAPY INTERRUPTED 223 0.0031
800 INTERSTITIAL LUNG DISEASE 151 0.0031
801 RASH ERYTHEMATOUS 149 0.0031
802 PARAESTHESIA 487 0.0031
803 MENTAL IMPAIRMENT 75 0.0031
804 HOT FLUSH 233 0.0031
805 SKIN DISCOLOURATION 142 0.0031
806 LUNG NEOPLASM MALIGNANT 127 0.0031
807 EJECTION FRACTION DECREASED 48 0.0031
808 MUSCLE TIGHTNESS 50 0.0031
809 MYELOSUPPRESSION 111 0.0031
810 SYNCOPE 308 0.0031
811 LIVER FUNCTION TEST ABNORMAL 89 0.0031
812 STOMATITIS 185 0.0030
813 IMPAIRED HEALING 100 0.0030
814 HYPERTHYROIDISM 44 0.0030
815 ECONOMIC PROBLEM 46 0.0030
816 SPEECH DISORDER 159 0.0030
817 DRUG EXPOSURE DURING PREGNANCY 103 0.0030
818 UNRESPONSIVE TO STIMULI 78 0.0030
819 OSTEONECROSIS 99 0.0030
820 GAIT DISTURBANCE 576 0.0030
821 PAIN IN JAW 85 0.0030
822 EYE PAIN 169 0.0030
823 RHEUMATOID ARTHRITIS 340 0.0030
824 CARDIOVASCULAR DISORDER 76 0.0030
825 NEUROPATHY PERIPHERAL 284 0.0030
826 HALLUCINATION 225 0.0030
827 THERAPY CESSATION 152 0.0030
828 DRUG RESISTANCE 76 0.0030
829 FLUID OVERLOAD 43 0.0030
830 LIVER DISORDER 131 0.0030
831 SEIZURE 341 0.0029
832 GASTRIC ULCER 56 0.0029
833 INTERNATIONAL NORMALISED RATIO INCREASED 84 0.0029
834 ACUTE RESPIRATORY DISTRESS SYNDROME 52 0.0029
835 HYPERKALAEMIA 103 0.0029
836 URINARY RETENTION 98 0.0029
837 DEPRESSED LEVEL OF CONSCIOUSNESS 116 0.0029
838 INFLUENZA LIKE ILLNESS 241 0.0029
839 PHOTOPHOBIA 55 0.0029
840 MEMORY IMPAIRMENT 401 0.0029
841 PSYCHOTIC DISORDER 86 0.0029
842 BLOOD CREATINE PHOSPHOKINASE INCREASED 83 0.0029
843 RASH MACULO-PAPULAR 64 0.0029
844 ALOPECIA 558 0.0028
845 MULTI-ORGAN FAILURE 49 0.0028
846 HIP FRACTURE 91 0.0028
847 GASTRIC DISORDER 97 0.0028
848 MUCOSAL INFLAMMATION 74 0.0028
849 DISORIENTATION 112 0.0028
850 HYPERSOMNIA 81 0.0028
851 ASCITES 83 0.0028
852 LOWER LIMB FRACTURE 54 0.0028
853 MENTAL STATUS CHANGES 78 0.0028
854 SENSORY DISTURBANCE 45 0.0028
855 MUSCULOSKELETAL PAIN 146 0.0028
856 INCORRECT DOSE ADMINISTERED 636 0.0028
857 INJECTION SITE BRUISING 222 0.0028
858 DEMENTIA 77 0.0028
859 INJECTION SITE SWELLING 211 0.0028
860 HEAD INJURY 87 0.0027
861 PRURITUS GENERALISED 59 0.0027
862 NERVOUS SYSTEM DISORDER 85 0.0027
863 BRADYCARDIA 144 0.0027
864 ABNORMAL BEHAVIOUR 107 0.0027
865 SHOCK 62 0.0027
866 PRESCRIBED OVERDOSE 52 0.0027
867 BONE PAIN 156 0.0027
868 DRUG EFFECT DECREASED 143 0.0027
869 LOSS OF CONSCIOUSNESS 340 0.0027
870 BLOOD LACTATE DEHYDROGENASE INCREASED 42 0.0026
871 MENTAL DISORDER 115 0.0026
872 BLISTER 148 0.0026
873 SKIN EXFOLIATION 222 0.0026
874 SCAR 45 0.0026
875 EYE IRRITATION 151 0.0026
876 DIPLOPIA 68 0.0026
877 CEREBROVASCULAR ACCIDENT 442 0.0026
878 HEPATIC CIRRHOSIS 49 0.0026
879 FLUSHING 265 0.0026
880 CARDIAC ARREST 215 0.0026
881 GAIT INABILITY 87 0.0026
882 HEMIPARESIS 44 0.0026
883 OSTEOMYELITIS 47 0.0026
884 JOINT STIFFNESS 68 0.0026
885 FRACTURE 49 0.0026
886 THINKING ABNORMAL 48 0.0026
887 KNEE ARTHROPLASTY 54 0.0026
888 DISTURBANCE IN ATTENTION 138 0.0026
889 SKIN CANCER 55 0.0026
890 CHOLESTASIS 49 0.0025
891 GLYCOSYLATED HAEMOGLOBIN INCREASED 64 0.0025
892 MOBILITY DECREASED 182 0.0025
893 ACTIVITIES OF DAILY LIVING IMPAIRED 50 0.0025
894 SEROTONIN SYNDROME 48 0.0025
895 NO ADVERSE EVENT 452 0.0025
896 FEAR 67 0.0025
897 BALANCE DISORDER 214 0.0025
898 RENAL FAILURE ACUTE 105 0.0025
899 STEVENS-JOHNSON SYNDROME 55 0.0025
900 RASH GENERALISED 64 0.0025
901 ERUCTATION 47 0.0024
902 DYSSTASIA 70 0.0024
903 ANGER 81 0.0024
904 ACUTE MYOCARDIAL INFARCTION 70 0.0024
905 COGNITIVE DISORDER 110 0.0024
906 GALLBLADDER DISORDER 42 0.0024
907 INJECTION SITE PAIN 719 0.0023
908 UNDERDOSE 171 0.0023
909 PLATELET COUNT DECREASED 249 0.0023
910 MOVEMENT DISORDER 75 0.0023
911 EMOTIONAL DISORDER 72 0.0023
912 INJECTION SITE URTICARIA 57 0.0023
913 AMNESIA 151 0.0023
914 LEUKOPENIA 116 0.0023
915 UNEVALUABLE EVENT 175 0.0023
916 BLOOD GLUCOSE INCREASED 435 0.0023
917 MYOCARDIAL INFARCTION 402 0.0023
918 DYSKINESIA 93 0.0023
919 METABOLIC ACIDOSIS 73 0.0023
920 DRY SKIN 302 0.0023
921 DYSARTHRIA 85 0.0023
922 RESPIRATORY ARREST 62 0.0022
923 THROMBOCYTOPENIA 247 0.0022
924 DISEASE PROGRESSION 260 0.0022
925 DELIRIUM 76 0.0022
926 DRUG EFFECT INCOMPLETE 79 0.0022
927 CEREBRAL INFARCTION 53 0.0022
928 MUSCLE TWITCHING 50 0.0022
929 LACTIC ACIDOSIS 70 0.0022
930 PRODUCT PHYSICAL ISSUE 43 0.0021
931 CEREBRAL HAEMORRHAGE 76 0.0021
932 INJECTION SITE RASH 65 0.0021
933 VISUAL ACUITY REDUCED 70 0.0021
934 ERECTILE DYSFUNCTION 54 0.0021
935 DRUG DOSE OMISSION BY DEVICE 163 0.0021
936 ROAD TRAFFIC ACCIDENT 87 0.0021
937 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 418 0.0021
938 INJECTION SITE PRURITUS 137 0.0020
939 RHABDOMYOLYSIS 85 0.0020
940 FEBRILE NEUTROPENIA 135 0.0020
941 NEOPLASM MALIGNANT 135 0.0020
942 HYPOGLYCAEMIA 98 0.0020
943 ABORTION SPONTANEOUS 79 0.0020
944 FEMUR FRACTURE 61 0.0020
945 ABNORMAL DREAMS 54 0.0020
946 INJECTION SITE ERYTHEMA 241 0.0019
947 EPILEPSY 59 0.0019
948 CONVULSION 110 0.0019
949 ANHEDONIA 50 0.0019
950 WHITE BLOOD CELL COUNT DECREASED 206 0.0019
951 BLINDNESS 77 0.0019
952 NEUTROPHIL COUNT DECREASED 77 0.0019
953 RENAL INJURY 55 0.0018
954 PSORIASIS 240 0.0018
955 JAUNDICE 48 0.0018
956 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 52 0.0018
957 EMOTIONAL DISTRESS 214 0.0018
958 EXTRA DOSE ADMINISTERED 71 0.0018
959 INJECTION SITE MASS 64 0.0017
960 BONE DENSITY DECREASED 54 0.0017
961 NEEDLE ISSUE 50 0.0017
962 INJECTION SITE REACTION 118 0.0017
963 NEUTROPENIA 231 0.0017
964 INJURY 119 0.0017
965 COMA 79 0.0017
966 EXPIRED PRODUCT ADMINISTERED 55 0.0017
967 SUICIDAL IDEATION 151 0.0016
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 116 0.0016
969 ELECTROCARDIOGRAM QT PROLONGED 58 0.0016
970 CARDIO-RESPIRATORY ARREST 67 0.0016
971 PAIN OF SKIN 43 0.0016
972 INCORRECT ROUTE OF DRUG ADMINISTRATION 57 0.0016
973 DEATH 1320 0.0015
974 INJECTION SITE HAEMORRHAGE 122 0.0015
975 HEPATIC FUNCTION ABNORMAL 57 0.0015
976 PRODUCT SUBSTITUTION ISSUE 86 0.0015
977 WITHDRAWAL SYNDROME 61 0.0015
978 BLOOD GLUCOSE DECREASED 68 0.0014
979 MULTIPLE SCLEROSIS 64 0.0013
980 PRODUCT STORAGE ERROR 114 0.0013
981 ACCIDENTAL EXPOSURE TO PRODUCT 129 0.0013
982 SKIN IRRITATION 56 0.0012
983 OVERDOSE 263 0.0012
984 VAGINAL HAEMORRHAGE 50 0.0012
985 DERMATITIS ATOPIC 55 0.0010
986 DEVICE LEAKAGE 45 0.0010
987 TOXICITY TO VARIOUS AGENTS 165 0.0010
988 PROSTATE CANCER 75 0.0009
989 DRUG DEPENDENCE 148 0.0009
990 MALIGNANT NEOPLASM PROGRESSION 88 0.0009
991 SKIN BURNING SENSATION 59 0.0008
992 BREAST CANCER 70 0.0008